Organizations Filed Purposes:
THE ORGANIZATION PROVIDES FINANCIAL SUPPORT FOR RESEARCH AND CLINICAL TRIALS FOR A NATIONAL CONSORTIUM OF HOSPITALS FOCUSED ON SAVING KIDS FIGHTING NEUROBLASTOMA CANCER.
THE ORGANIZATION PROVIDES FINANCIAL SUPPORT FOR CHILDHOOD CANCER CLINICAL TRIALS FOR A NATIONAL CONSORTIUM.
BEAT NB FUNDS RESEARCH FOR NEUROBLASTOMA TREATMENT THAT USES TARGETED THERAPY, ORAL DRUGS, LOW SIDE EFFECTS, AND TARGETS PREVENTING RELAPSE OF TREATING RELAPSE WITHOUT PUNITIVE THERAPIES. THE ORGANIZATION HAS HELPED TO BUILD AN INTERNATIONAL TEAM OF RESEARCH AND CLINICAL COLLABORATORS TO ENSURE KIDS ACROSS THE WORLD HAVE ACCESS TO THESE THERAPIES, AND CREATED A CONSORTIUM OF 45+ CHILDREN'S HOSPITALS AND RESEARCH LOCATIONS ACROSS THE UNITED STATES. IN 2019, BEAT NB GRANTED $1,250,000 FOR RESEARCH ON NEUROBLASTOMA CANCER.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Kyle Matthews | EXECUTIVE DIRECTOR/CLERK | 40 | $97,528 |
| Tom Secaur | CHAIRMAN THROUGH APRIL 2019 | 5 | $0 |
| Brian Shactman | DIRECTOR | 5 | $0 |
| Kyla Callahan | DIRECTOR | 5 | $0 |
| John Foley | CHAIRMAN AS OF APRIL 2019 | 5 | $0 |
| Eric Caisse | TREASURER | 5 | $0 |
| Patrick Lacey | PRESIDENT | 20 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202001229349301015_public.xml